Abstract:Alport syndrome is a genetic disease caused by mutations in type IV collagen and is characterized by progressive kidney disease. The Col4 alpha 3(-/-) mouse model recapitulates the main features of human Alport syndrome. Previously, it was reported that kidney microRNA-21 (miR-21) expression is significantly increased in Col4 alpha 3(-/-) mice, and administration of anti-miR-21 oligonucleotides (anti-miR-21) attenuates kidney disease progression in Col4 alpha 3(-/-) mice, indicating that miR-21 is a viable therapeutic target for Alport syndrome. However, the expression pattern of miR-21 in the kidneys of patients with human Alport syndrome has not been evaluated. Paraffin-embedded kidney specimens were obtained from 27 patients with Alport syndrome and from 10 normal controls. They were evaluated for miR-21 expression and for in situ hybridization and mRNA expression by quantitative polymerase chain reaction. In addition, anti-miR-21 was administrated to Col4 alpha 3(-/-) mice at different stages of disease, and changes in proteinuria, kidney function, and survival were monitored. Transcriptomic analysis of mouse kidney was conducted using RNA sequencing. miR-21 expression was significantly elevated in kidney specimens from patients with Alport syndrome compared to normal controls. Elevated renal miR-21 expression positively correlated with 24 h urine protein, serum blood urea nitrogen, serum creatinine, and severity of kidney pathology. On histological evaluation, high levels of miR-21 were localized to damaged tubular epithelial cells and glomeruli. Kidney specimens from both humans and mice with Alport syndrome exhibited abnormal expression of genes involved in kidney injury, fibrosis, inflammation, mitochondrial function, and lipid metabolism. Administration of anti-miR-21 to Alport mice resulted in slowing of kidney function decline, partial reversal of abnormal gene expression associated with disease pathology, and improved survival. Increased levels of miR-21 in human Alport kidney samples showed a correlation with kidney disease severity measured by proteinuria, biomarkers of kidney function, and kidney histopathology scores. These human data, combined with the finding that a reduction of miR-21 in Col4 alpha 3(-/-) mice improves kidney phenotype and survival, support miR-21 as a viable therapeutic target for the treatment of Alport syndrome.

Characterization of Ocular Morphology in Col4a3-/- Mice as a Murine Model for Alport Syndrome

Ultrastructural and Immunofluorescence Analysis of Anterior Lens Capsules in Autosomal Recessive Alport Syndrome.

A mouse model for X-linked Alport syndrome induced by Del-ATGG in the Col4a5 gene

Quantitative Analysis of Type IV Collagen Subchains in the Glomerular Basement Membrane of Patients with Alport Syndrome with Confocal Microscopy.

A Novel Splice Site Mutation In The Col4a5 Gene In A Chinese Female Patient With Rare Ocular Abnormalities

A Clinicopathological Study of Alport Syndrome and Detection of Type IV Collagen Chains in Alport Patients.

Four novel mutations identified in the COL4A3, COL4A4 and COL4A5 genes in 10 families with Alport syndrome

Establishment of Microrna, Transcript and Protein Regulatory Networks in Alport Syndrome Induced Pluripotent Stem Cells

Pharmacological approach and diagnosis for Alport syndrome

Detection of COL4A5 Gene Mutations in Chinese Patients with Alport's Syndrome

Correlation Between Mrna Expression Level of the Mutant COL4A5 Gene and Phenotypes of XLAS Females.

Adverse effects of Alport syndrome-related Gly missense mutations on collagen type IV: Insights from molecular simulations and experiments

Identification of a Novel COL4A5 Mutation in a Chinese Family with X-linked Alport Syndrome Using Exome Sequencing.

Dysregulated Expression of Microrna-21 and Disease-Related Genes in Human Patients and in a Mouse Model of Alport Syndrome

Features of Phenotype and Genotype in Chinese Alport Syndrome Patients

Novel Mutations In Col4a3, Col4a4, And Col4a5 In Chinese Patients With Alport Syndrome

A Novel COL4A5 Mutation Identified in a Chinese Han Family Using Exome Sequencing.

Tauroursodeoxycholic Acid Ameliorates Renal Injury Induced by COL4A3 Mutation

A Novel Deep Learning Approach for Analyzing Glomerular Basement Membrane Lesions in a Mouse Model of X-Linked Alport Syndrome

[Features of Clinical Phenotype and Genotype in Alport Syndrome: a Monocentric Study].

A Novel<i>COL4A5</i>Mutation Identified in a Chinese Han Family Using Exome Sequencing